Currently holds a position at AVROBIO Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | AVROBIO Inc | Feb. 1, 2016 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-15 | 2024-03-15 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
10,411
-1.3%
40.62422,895 USD |
10,411 -1.3% | 40.62 | 422,895 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
7,292
-0.9%
39.73289,711 USD |
7,292 -0.9% | 39.73 | 289,711 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
781
-0.0%
41.5132,419 USD |
781 -0.0% | 41.51 | 32,419 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
10,846
-0.2%
40.66440,998 USD |
10,846 -0.2% | 40.66 | 440,998 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
34,473
-0.7%
39.731,369,612 USD |
34,473 -0.7% | 39.73 | 1,369,612 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
1,386
-0.2%
42.8459,376 USD |
1,386 -0.2% | 42.84 | 59,376 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
22,779
-2.7%
42.19961,046 USD |
22,779 -2.7% | 42.19 | 961,046 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
6,686
-0.1%
42.84286,428 USD |
6,686 -0.1% | 42.84 | 286,428 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
108,404
-2.3%
42.194,573,565 USD |
108,404 -2.3% | 42.19 | 4,573,565 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
1,819
-0.2%
42.5277,344 USD |
1,819 -0.2% | 42.52 | 77,344 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
26,452
-3.0%
41.941,109,397 USD |
26,452 -3.0% | 41.94 | 1,109,397 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
8,581
-0.2%
42.52364,864 USD |
8,581 -0.2% | 42.52 | 364,864 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
126,066
-2.6%
41.945,287,208 USD |
126,066 -2.6% | 41.94 | 5,287,208 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
1,045
-0.1%
43.4245,374 USD |
1,045 -0.1% | 43.42 | 45,374 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
7,837
-0.9%
42.77335,188 USD |
7,837 -0.9% | 42.77 | 335,188 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
5,122
-0.1%
43.42222,397 USD |
5,122 -0.1% | 43.42 | 222,397 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
37,180
-0.7%
42.771,590,189 USD |
37,180 -0.7% | 42.77 | 1,590,189 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
21,592
-2.4%
30.29654,022 USD |
21,592 -2.4% | 30.29 | 654,022 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
77,128
-1.5%
30.292,336,207 USD |
77,128 -1.5% | 30.29 | 2,336,207 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
6,071
-0.7%
29.96181,887 USD |
6,071 -0.7% | 29.96 | 181,887 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
21,683
-0.4%
29.96649,623 USD |
21,683 -0.4% | 29.96 | 649,623 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
717
-0.1%
30.0021,510 USD |
717 -0.1% | 30.00 | 21,510 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
2,561
-0.1%
30.0076,830 USD |
2,561 -0.1% | 30.00 | 76,830 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
3,733
-0.4%
34.02126,997 USD |
3,733 -0.4% | 34.02 | 126,997 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
3,919
-0.4%
33.34130,659 USD |
3,919 -0.4% | 33.34 | 130,659 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
15,324
-1.6%
32.33495,425 USD |
15,324 -1.6% | 32.33 | 495,425 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
28,329
-2.9%
31.44890,664 USD |
28,329 -2.9% | 31.44 | 890,664 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
31,584
-3.2%
30.28956,364 USD |
31,584 -3.2% | 30.28 | 956,364 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
13,335
-0.3%
34.02453,657 USD |
13,335 -0.3% | 34.02 | 453,657 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
13,997
-0.3%
33.34466,660 USD |
13,997 -0.3% | 33.34 | 466,660 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
54,737
-1.1%
32.331,769,647 USD |
54,737 -1.1% | 32.33 | 1,769,647 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
101,189
-1.9%
31.443,181,382 USD |
101,189 -1.9% | 31.44 | 3,181,382 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
112,819
-2.1%
30.283,416,159 USD |
112,819 -2.1% | 30.28 | 3,416,159 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
21,085
-2.1%
30.00632,550 USD |
21,085 -2.1% | 30.00 | 632,550 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
75,312
-1.4%
30.002,259,360 USD |
75,312 -1.4% | 30.00 | 2,259,360 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
27,038
-2.6%
30.02811,681 USD |
27,038 -2.6% | 30.02 | 811,681 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
96,581
-1.7%
30.022,899,362 USD |
96,581 -1.7% | 30.02 | 2,899,362 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
1,044
-0.1%
31.0832,448 USD |
1,044 -0.1% | 31.08 | 32,448 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
3,727
-0.1%
31.08115,835 USD |
3,727 -0.1% | 31.08 | 115,835 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
15,804
-1.5%
30.57483,128 USD |
15,804 -1.5% | 30.57 | 483,128 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
56,455
-1.0%
30.571,725,829 USD |
56,455 -1.0% | 30.57 | 1,725,829 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
26,383
-2.4%
30.23797,558 USD |
26,383 -2.4% | 30.23 | 797,558 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
94,239
-1.7%
30.232,848,845 USD |
94,239 -1.7% | 30.23 | 2,848,845 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
19,915
-1.8%
30.00597,450 USD |
19,915 -1.8% | 30.00 | 597,450 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
PS Planned sale |
71,135
-1.2%
30.002,134,050 USD |
71,135 -1.2% | 30.00 | 2,134,050 USD | |
2022-01-11 | 2022-01-11 |
Vigil Neuroscience Inc
(VIGL)
|
B Purchase |
535,000
+12.5%
14.007,490,000 USD |
535,000 +12.5% | 14.00 | 7,490,000 USD | |
2021-08-12 | 2021-08-11 |
Kymera Therapeutics Inc
(KYMR)
|
S Sale |
242,133
-100.0%
61.0014,770,113 USD |
242,133 -100.0% | 61.00 | 14,770,113 USD | |
2021-03-16 | 2021-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
S Sale |
229,350
-100.0%
56.5012,958,275 USD |
229,350 -100.0% | 56.50 | 12,958,275 USD | |
2020-07-01 | 2020-06-29 |
Magenta Therapeutics Inc
(MGTA)
|
B Purchase |
1,250,000
+inf%
8.0010,000,000 USD |
1,250,000 +inf% | 8.00 | 10,000,000 USD | |
2019-07-23 | 2019-07-19 |
AVROBIO Inc
(AVRO)
|
B Purchase |
810,811
+17.0%
18.5015,000,004 USD |
810,811 +17.0% | 18.50 | 15,000,004 USD | |
2019-03-22 | 2019-03-20 |
Magenta Therapeutics Inc
(MGTA)
|
S Sale |
14,245
-100.0%
17.86254,416 USD |
14,245 -100.0% | 17.86 | 254,416 USD |